Cargando…

Screening for Plasminogen Mutations in Hereditary Angioedema Patients

Hereditary angioedema (HAE) is a rare disease belonging to the group of bradykinin-mediated angioedemas, characterized by recurring edematous episodes involving the subcutaneous and/or submucosal tissues. Most cases of HAE are caused by mutations in the SERPING1 gene encoding C1-inhibitor (C1-INH-HA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farkas, Henriette, Dóczy, Anna, Szabó, Edina, Varga, Lilian, Csuka, Dorottya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998782/ https://www.ncbi.nlm.nih.gov/pubmed/33799813 http://dx.doi.org/10.3390/genes12030402

Ejemplares similares

Overview of SERPING1 Variations Identified in Hungarian Patients With Hereditary Angioedema
por: Szabó, Edina, et al.
Publicado: (2022)

455 Characterization of the Factors Triggering an Edematous Attack in Hereditary Angioedema
por: Zotter, Zsuzsanna, et al.
Publicado: (2012)

Frequency of the virilising effects of attenuated androgens reported by women with hereditary angioedema
por: Zotter, Zsuzsanna, et al.
Publicado: (2014)

Home treatment with conestat alfa in attacks of hereditary angioedema due to C1-inhibitor deficiency
por: Farkas, Henriette, et al.
Publicado: (2015)

The influence of trigger factors on hereditary angioedema due to C1-inhibitor deficiency
por: Zotter, Zsuzsanna, et al.
Publicado: (2014)

458 Differences of Complement Activation Profile between Type I and Type II of Hereditary Angioedema Due to C1-inhibitor Deficiency
por: Csuka, Dorottya, et al.
Publicado: (2012)

The effect of long-term danazol treatment on haematological parameters in hereditary angioedema
por: Kőhalmi, Kinga Viktória, et al.
Publicado: (2016)

Neutrophil activation during attacks in patients with hereditary angioedema due to C1-inhibitor deficiency
por: Veszeli, Nóra, et al.
Publicado: (2015)

Diagnosing Pediatric Patients With Hereditary C1-Inhibitor Deficiency—Experience From the Hungarian Angioedema Center of Reference and Excellence
por: Andrási, Noémi, et al.
Publicado: (2022)

The characteristics of upper airway edema in hereditary and acquired angioedema with C1‐inhibitor deficiency
por: Balla, Zsuzsanna, et al.
Publicado: (2021)

86 The Efficacy and Safety of Human Plasma-derived C1-Inhibitor Concentrate Administered for the Treatment of Attacks in Pediatric Patients with Hereditary Angioedema Due to C1-Inhibitor Deficiency
por: Farkas, Henriette, et al.
Publicado: (2012)

Comprehensive study into the activation of the plasma enzyme systems during attacks of hereditary angioedema due to C1-inhibitor deficiency
por: Csuka, Dorottya, et al.
Publicado: (2015)

163 The Efficacy of Human Plasma-Derived C1-Inhibitor Concentrate Used for Prophylactic Treatment in Patients With Hereditary Angioedema Due to C1-Inhibitor Deficiency
por: Csuka, Dorottya, et al.
Publicado: (2012)

Glucocorticoid receptor gene polymorphisms in hereditary angioedema with C1-inhibitor deficiency
por: Zotter, Zsuzsanna, et al.
Publicado: (2017)

Application of a dried blood spot based proteomic and genetic assay for diagnosing hereditary angioedema
por: Iuraşcu, Marius‐Ionuţ, et al.
Publicado: (2023)

Anti-cholesterol antibody levels in hereditary angioedema
por: Varga, Lilian, et al.
Publicado: (2007)

Ecallantide is a novel treatment for attacks of hereditary angioedema due to C1 inhibitor deficiency
por: Farkas, Henriette, et al.
Publicado: (2011)

Angioedema Without Wheals: Challenges in Laboratorial Diagnosis
por: Grumach, Anete S., et al.
Publicado: (2021)

Human Plasma-Derived, Nanofiltered, C1-Inhibitor Concentrate (Cinryze®), a Novel Therapeutic Alternative for the Management of Hereditary Angioedema Resulting from C1-Inhibitor Deficiency
por: Farkas, Henriette, et al.
Publicado: (2012)

Erratum to: Human Plasma-Derived, Nanofiltered C1-Inhibitor Concentrate (Cinryze®), a Novel Therapeutic Alternative for the Management of Hereditary Angioedema Resulting From C1-Inhibitor Deficiency
por: Farkas, Henriette, et al.
Publicado: (2012)

Management of upper airway edema caused by hereditary angioedema
por: Farkas, Henriette
Publicado: (2010)

Pathways of Neutrophil Granulocyte Activation in Hereditary Angioedema with C1 Inhibitor Deficiency
por: Kajdácsi, Erika, et al.
Publicado: (2021)

Pediatric hereditary angioedema due to C1-inhibitor deficiency
por: Farkas, Henriette
Publicado: (2010)

Searching for Genetic Biomarkers for Hereditary Angioedema Due to C1-Inhibitor Deficiency (C1-INH-HAE)
por: Parsopoulou, Faidra, et al.
Publicado: (2022)

The Global Registry for Hereditary Angioedema due to C1-Inhibitor Deficiency
por: Zanichelli, Andrea, et al.
Publicado: (2021)

Mutant plasminogen in hereditary angioedema is bypassing FXII/kallikrein to generate bradykinin
por: Hintze, Stefan, et al.
Publicado: (2023)

National survey on clinical and genetic characteristics of patients with hereditary angioedema in Latvia
por: Kanepa, Adine, et al.
Publicado: (2023)

Patterns of C1-Inhibitor/Plasma Serine Protease Complexes in Healthy Humans and in Hereditary Angioedema Patients
por: Kajdácsi, Erika, et al.
Publicado: (2020)

Decreased adhesion to endothelium leads to elevated neutrophil granulocyte count in hereditary angioedema patients
por: Kajdácsi, Erika, et al.
Publicado: (2023)

WAO Guideline for the Management of Hereditary Angioedema
por: Craig, Timothy, et al.
Publicado: (2012)

Canadian hereditary angioedema guideline
por: Betschel, Stephen, et al.
Publicado: (2014)

How Angioedema Quality of Life Questionnaire Can Help Physicians in Treating C1-Inhibitor Deficiency Patients?
por: Balla, Zsuzsanna, et al.
Publicado: (2021)

Patient‐physician interactions in hereditary angioedema—Key learnings from the coronavirus disease 2019 pandemic
por: Maurer, Marcus, et al.
Publicado: (2023)

Hypersensitivity reactions amongst Hungarian Patients with Hereditary Angioedema due to C1-Inhibitor Deficiency
por: Horváth, Hanga Réka, et al.
Publicado: (2023)

The analysis of the effect of the COVID-19 pandemic on patients with hereditary angioedema type I and type II
por: Szilágyi, Dávid, et al.
Publicado: (2023)

Hereditary angioedema
por: Lesser, Helen, et al.
Publicado: (2021)

Hereditary Angioedema
por: Banerjee, Anjali, et al.
Publicado: (2023)

Continued icatibant use across recurrent attacks in adolescents with hereditary angioedema
por: Farkas, Henriette, et al.
Publicado: (2021)

Long term follow-up of complement parameters to improve the management of acquired angioedema due to C1-inhibitor deficiency
por: Polai, Zsofia, et al.
Publicado: (2022)

Diagnosis and screening of patients with hereditary angioedema in primary care
por: Henao, Maria Paula, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ugrlk3976le7ojp297mcnchp44